Feasibility of Administering High-Dose (131)I-MIBG Therapy to Children with High-Risk Neuroblastoma without Lead-Lined Rooms

BACKGROUND: Although (131)I-metaiodobenzylguanidine therapy ((131)I-MIBG) is increasingly used for children with high-risk neuroblastoma, a paucity of lead-lined rooms limits its wider use. We implemented radiation safety procedures to comply with New York City Department of Health and Mental Hygien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Blood Cancer
Autors principals: Chu, Bae P., Horan, Christopher, Basu, Ellen, Dauer, Lawrence, Williamson, Matthew, Carrasquillo, Jorge A., Pandit-Taskar, Neeta, Modak, Shakeel
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801722/
https://ncbi.nlm.nih.gov/pubmed/26773712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25892
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars